Home › Companies › ROIVANT SCIENCES LTD. › 2023-2024
At ROIVANT SCIENCES LTD.'s shareholder meeting held September 12, 2023, in the 2023-2024 proxy season, 63 asset managers reported how they voted on 3 ballot items in their SEC Form N-PX filings, covering 545 separate fund positions. On the most widely held item on that ballot — To elect the Board's two nominees for Class II Director to serve for a three-year term: Daniel… — ROIVANT SCIENCES LTD.'s filing reports the nominee as elected, with 72% support of the votes cast (FOR divided by FOR plus WITHHELD, because this ballot offered only for and withhold; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: ROIVANT SCIENCES LTD.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on September 15, 2023.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and ROIVANT SCIENCES LTD.’s Form 8-K, filed September 15, 2023 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of September 12, 2023: 3 items on ROIVANT SCIENCES LTD.’s Form 8-K, filed September 15, 2023: 2 elected · 1 approved.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore ROIVANT SCIENCES LTD. in the interactive database Compare manager voting policies
These tallies are ROIVANT SCIENCES LTD.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed September 15, 2023 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Daniel Gold | 480,335,783 | -- | -- | 189,651,604 | 40,276,885 | 72% | Elected | — |
| Elect Director: Meghan FitzGerald, DrPH | 668,955,006 | -- | -- | 1,032,381 | 40,276,885 | 99.8% | Elected | — |
| 2. The appointment of Ernst & Young LLP ("EY") to serve as the Company's independent registered public accounting firm for the fiscal year ending March 31, 2024, and to appoint EY as the Company's auditor for statutory purposes under the Bermuda Com | 709,944,901 | 65,948 | 253,423 | -- | -- | 99.9% | Approved | a majority of the votes cast |
Source: ROIVANT SCIENCES LTD., Form 8-K, filed with the SEC on September 15, 2023 — read the filing on EDGAR.
Each item below shows how the 63 asset managers that disclosed a ROIVANT SCIENCES LTD. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 4 wordings of this item as funds reported it.
72% Majority: yes · of votes cast
Description as filed by funds: To elect the Board's two nominees for Class II Director to serve for a three-year term: Daniel Gold
ROIVANT SCIENCES LTD.’s own tally for this item (“Elect Director: Daniel Gold”): 480,335,783 for, 189,651,604 withheld, per its Form 8-K filed September 15, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “(1) Shareholders elected the individuals named below to serve as Class II directors of the Company, to hold office until the date of the annual general meeting of shareholders following the fiscal year ending March 31, 2026, and until their successors are duly elected and qualified, or until such d…”
Support: 72% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 63 asset managers below reported 13,460,792 for, 48,143,012 withheld, 1,069,670 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 0 | 0 | 0 | 20,154,749 | Withhold |
| Vanguard | 10,917,884 | 0 | 0 | 0 | For |
| State Street | 0 | 0 | 0 | 6,001,162 | Withhold |
| BlackRock | 0 | 0 | 0 | 5,852,877 | Withhold |
| Morgan Stanley | 0 | 0 | 0 | 5,336,273 | Withhold |
| T. Rowe Price | 0 | 0 | 0 | 1,715,989 | Withhold |
| MUTUAL FUND SERIES TRUST | 0 | 0 | 0 | 1,690,300 | Withhold |
| Invesco | 0 | 0 | 0 | 1,119,688 | Withhold |
| JANUS INVESTMENT FUND | 812,519 | 0 | 0 | 0 | For |
| Brighthouse | 76,103 | 0 | 0 | 731,368 | Mixed |
| Victory Capital | 0 | 0 | 0 | 699,869 | Withhold |
| TIAA | 640,474 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 0 | 628,320 | Withhold |
| Transamerica | 0 | 0 | 0 | 592,201 | Withhold |
| FRANKLIN STRATEGIC SERIES | 0 | 0 | 0 | 518,500 | Withhold |
| Bridge Builder Trust | 0 | 0 | 466,335 | 0 | Abstain |
| Aberdeen | 433,637 | 0 | 0 | 0 | For |
| Jackson National | 0 | 0 | 433,128 | 0 | Abstain |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 432,238 | Withhold |
| First Trust | 0 | 0 | 0 | 386,499 | Withhold |
| Delaware/Macquarie | 0 | 0 | 0 | 338,181 | Withhold |
| Mercer Funds | 0 | 0 | 0 | 269,246 | Withhold |
| Equitable | 0 | 0 | 0 | 256,583 | Withhold |
| Clough Global Opportunities Fund | 242,200 | 0 | 0 | 0 | For |
| MassMutual | 0 | 0 | 0 | 205,000 | Withhold |
Showing the 25 largest of 63 asset managers. All 63 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99.8% Majority: yes · of votes cast
Description as filed by funds: To elect the Board's two nominees for Class II Director to serve for a three-year term: Meghan FitzGerald, DrPH
ROIVANT SCIENCES LTD.’s own tally for this item (“Elect Director: Meghan FitzGerald, DrPH”): 668,955,006 for, 1,032,381 withheld, per its Form 8-K filed September 15, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “(1) Shareholders elected the individuals named below to serve as Class II directors of the Company, to hold office until the date of the annual general meeting of shareholders following the fiscal year ending March 31, 2026, and until their successors are duly elected and qualified, or until such d…”
Support: 99.8% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 63 asset managers below reported 61,608,332 for, 338,181 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 20,154,749 | 0 | 0 | 0 | For |
| Vanguard | 10,917,884 | 0 | 0 | 0 | For |
| State Street | 6,001,162 | 0 | 0 | 0 | For |
| BlackRock | 5,852,877 | 0 | 0 | 0 | For |
| Morgan Stanley | 5,336,273 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,715,989 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 1,690,300 | 0 | 0 | 0 | For |
| Invesco | 1,119,688 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 812,519 | 0 | 0 | 0 | For |
| Victory Capital | 699,869 | 0 | 0 | 0 | For |
| TIAA | 640,474 | 0 | 0 | 0 | For |
| Charles Schwab | 628,320 | 0 | 0 | 0 | For |
| Transamerica | 592,201 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 518,500 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 466,335 | 0 | 0 | 0 | For |
| Aberdeen | 433,637 | 0 | 0 | 0 | For |
| Jackson National | 433,128 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 432,238 | 0 | 0 | 0 | For |
| First Trust | 386,499 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 0 | 0 | 0 | 338,181 | Withhold |
| Mercer Funds | 269,246 | 0 | 0 | 0 | For |
| Equitable | 256,583 | 0 | 0 | 0 | For |
| Clough Global Opportunities Fund | 242,200 | 0 | 0 | 0 | For |
| MassMutual | 205,000 | 0 | 0 | 0 | For |
| ProShares | 176,951 | 0 | 0 | 0 | For |
Showing the 25 largest of 63 asset managers. All 63 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.9% Approved · of votes cast
Description as filed by funds: To ratify the selection by the Audit Committee of the Board of Ernst & Young LLP as Roivant's independent registered public accounting firm for Roivant's fiscal year ending March 31, 2024, to appoint Ernst & Young LLP as auditor for statutory purposes under the Bermuda Companies Act 1981, as amended, for Roivant's fiscal year ending March 31, 2024, and to authorize the Board, through the Audit Committee, to set the remuneration for Ernst & Young LLP as Roivant's auditor for Roivant's fiscal year ending March 31, 2024.
ROIVANT SCIENCES LTD.’s own tally for this item (“2. The appointment of Ernst & Young LLP ("EY") to serve as the Company's independent registered public accounting firm for the fiscal year ending March 31, 2024, and to appoint EY as the Company's auditor for statutory p”): 709,944,901 for, 65,948 against — passed, per its Form 8-K filed September 15, 2023 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “(2) Shareholders ratified the appointment of Ernst & Young LLP ("EY") to serve as the Company's independent registered public accounting firm for the fiscal year ending March 31, 2024, and to appoint EY as the Company's auditor for statutory purposes under the Bermuda Companies Act 1981, as amended…”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Voting standard, as the filing states it: a majority of the votes cast (“majority of the votes cast”).
The 63 asset managers below reported 61,946,513 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 20,154,749 | 0 | 0 | 0 | For |
| Vanguard | 10,917,884 | 0 | 0 | 0 | For |
| State Street | 6,001,162 | 0 | 0 | 0 | For |
| BlackRock | 5,852,877 | 0 | 0 | 0 | For |
| Morgan Stanley | 5,336,273 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,715,989 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 1,690,300 | 0 | 0 | 0 | For |
| Invesco | 1,119,688 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 812,519 | 0 | 0 | 0 | For |
| Victory Capital | 699,869 | 0 | 0 | 0 | For |
| TIAA | 640,474 | 0 | 0 | 0 | For |
| Charles Schwab | 628,320 | 0 | 0 | 0 | For |
| Transamerica | 592,201 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 518,500 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 466,335 | 0 | 0 | 0 | For |
| Aberdeen | 433,637 | 0 | 0 | 0 | For |
| Jackson National | 433,128 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 432,238 | 0 | 0 | 0 | For |
| First Trust | 386,499 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 338,181 | 0 | 0 | 0 | For |
| Mercer Funds | 269,246 | 0 | 0 | 0 | For |
| Equitable | 256,583 | 0 | 0 | 0 | For |
| Clough Global Opportunities Fund | 242,200 | 0 | 0 | 0 | For |
| MassMutual | 205,000 | 0 | 0 | 0 | For |
| ProShares | 176,951 | 0 | 0 | 0 | For |
Showing the 25 largest of 63 asset managers. All 63 are in the interactive database (link above).
Not shown here: this season’s fund filings also report 2 items from the meeting of September 10, 2024, which belongs to the 2024-2025 season. A meeting outside this season’s July 1 to June 30 window is not counted in this page’s items or in its totals of asset managers and fund votes.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 771,742,197 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 2.61% |
| 2 | Vanguard | 1.41% |
| 3 | State Street | 0.78% |
| 4 | BlackRock | 0.76% |
| 5 | Morgan Stanley | 0.69% |
| 6 | T. Rowe Price | 0.22% |
| 7 | MUTUAL FUND SERIES TRUST | 0.22% |
| 8 | Invesco | 0.15% |
| 9 | JANUS INVESTMENT FUND | 0.11% |
| 10 | Brighthouse | 0.10% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | 683 Capital Management, LLC | 0.05% |
| 2 | Corbin Capital Partners, L.P. | <0.01% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Dexxon Holdings | 13.33% | DEF14A |
| Roivant Sciences Ltd. | 12.52% | 13D |
| Ramaswamy Vivek | 10.75% | 13G |
| Vivek Ramaswamy | 10.75% | DEF14A |
| SVF Investments | 9.22% | DEF14A |
| Viking Global Entities | 8.99% | DEF14A |
| QVT Entities | 8.65% | DEF14A |
| QVT Financial LP | 8.53% | 13G |
| SB Investment Advisers (UK) Limited | 8.04% | 13G |
| FMR (Fidelity) | 7.87% | 13F |
Percentages above are of 771,742,197 shares outstanding, as reported by ROIVANT SCIENCES LTD. on its Form 10-Q dated August 10, 2023 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ROIVANT SCIENCES LTD.’s 10-Q dated August 10, 2023. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
ROIVANT SCIENCES LTD. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
proxyvotesnow.com, “ROIVANT SCIENCES (ROIV) 2023 Annual Meeting (2023-2024 season)”, https://proxyvotesnow.com/company/roivant-sciences-ltd/2024 (version of November 8, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.